Company news

TELA Bio, Inc. news in 2023

TELA Bio, Inc.'s news releases, calls and decks from 2023, newest first.

View company

TELA Bio to Take Part in Connecting the Dots

December 4, 2023

TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference

November 15, 2023

TELA Bio Reports Third Quarter 2023 Financial Results

November 8, 2023

TELA Bio to Announce Third Quarter 2023 Financial Results

October 25, 2023

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

September 17, 2023

TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

August 15, 2023

TELA Bio Reports Second Quarter 2023 Financial Results

August 8, 2023

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

July 25, 2023

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

June 14, 2023

TELA Bio to Participate in the Jefferies Global Healthcare Conference

May 24, 2023

TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

May 18, 2023

TELA Bio Reports First Quarter 2023 Financial Results

May 10, 2023

TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference

May 8, 2023

TELA Bio to Participate in the JMP Securities Life Sciences Conference

May 1, 2023

TELA Bio to Announce First Quarter 2023 Financial Results

April 26, 2023

TELA Bio Announces Pricing of Public Offering of Common Stock

April 17, 2023

TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023

March 28, 2023

TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

March 22, 2023

TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results

March 20, 2023

TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications

March 15, 2023

TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results

February 27, 2023

TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques

February 20, 2023

TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization

February 13, 2023

TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds

January 8, 2023

Calls in 2023

Decks in 2023